NCT00039390View on ClinicalTrials.gov

Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

May 31, 2007

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

capecitabine

Given orally (PO)

DRUG

gefitinib

Given PO

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

80217-3364

University of Colorado, Denver

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00039390 - Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter